Market revenue in 2023 | USD 203.6 million |
Market revenue in 2030 | USD 352.8 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.66% in 2023. Horizon Databook has segmented the Germany real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The growing prevalence of chronic diseases, such as respiratory diseases, stroke, and other chronic illnesses, is a major driver responsible for market growth. According to the WHO, over 170,000 people died in Germany due to the COVID-19 till March 2023.
The older population is often susceptible to cataract & refractive errors, hearing loss, back & neck pain, osteoarthritis, depression, chronic obstructive pulmonary disease, diabetes, and dementia. This drives the demand and adoption of RWE data and solutions. Moreover, innovation in product technologies and growing focus on providing cost effective treatment are fueling market growth in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account